UCB, INC.

Lobbying for UCB, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $340,000.00 expenses · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Pharmacy

HR 4993 - Joe Fiandra Access to Home Infusion Act

Trade (domestic/foreign)

Sec. 232 Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.